http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015057047-A9
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36434eba3b122f3ce920cc6b1fe9e289 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201 |
filingDate | 2014-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d270af70f2a70661505e36163653e578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eae46cdd446fca10a1118ba8581ddaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f1d39650c24ab8abfde5e60d539e69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80746107333f6c07108bfe0d56087faa |
publicationDate | 2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2015057047-A9 |
titleOfInvention | Process for obtaining a molecule serving as an antimicrobial peptide elicitor |
abstract | The invention relates to a method for the enzymatic synthesis of lithocholic acid oleate and for the efficient purification of same. The lithocholic acid oleate is a molecule that serves as an antimicrobial peptide elicitor and has an indirect immunomodulating antimicrobial activity by inducing the expression or overexpression of antimicrobial peptides and type II interferon (interferon-γ). Lithocholic acid oleate is a derivative of lithocholic acid esterified with oleic acid at the alpha 3-hydroxy position. It is a yellowish oily liquid at ambient temperature, having a molecular weight of 641 gr/mol and the chemical formula C 42 H 72 O 4 . This molecule can be used alone or combined with ascorbic acid and/or glucose, which this invention demonstrates are antimicrobial peptide elicitors, for the treatment of human chronic degenerative and infectious diseases. |
priorityDate | 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 446.